Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Das Thema chronische Unterbauch- und Viszeralschmerzen wird im Live-Webinar am 7. Mai von 17.30 bis 19 Uhr aus internistischer, gynäkologischer und psychologisch-neurowissenschaftlicher Perspektive beleuchtet. Besprochen werden krankheitsbedingte Ursachen, Mechanismen der kognitiven Schmerzmodulation sowie mögliche Therapieoptionen. Die Fortbildung ist mit 2 CME-Punkten zertifiziert. Melden Sie sich jetzt an!
Erweiterte Suche
Anmelden
nach oben
Current Sleep Medicine Reports
Erschienen in: Current Sleep Medicine Reports 4/2015

01.12.2015 | Sleep Related Breathing Disorders (T Lee-Chiong, Section Editor)

Obesity Hypoventilation Syndrome

verfasst von: Lee K. Brown

Erschienen in: Current Sleep Medicine Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

As the prevalence of obesity continues to rise, morbidity associated with obesity becomes more and more endemic. Of particular interest to pulmonary and sleep medicine physicians is the entity of obesity hypoventilation syndrome (OHS), formerly known as Pickwickian syndrome. Most patients with OHS also will be found to present with obstructive sleep apnea (OSA), which appears to play a major role in the pathogenesis of OHS. With or without OSA, the etiology of OHS may also be related to the extreme mechanical limitations imposed by obesity on the ventilatory apparatus. Treatment of OHS has been profoundly changed by the advent of non-invasive positive pressure therapies, including continuous positive airway pressure, bilevel positive airway pressure, and average volume-assured pressure support. Despite these advances, morbidity and mortality remain elevated in these individuals unless substantial weight loss can be achieved.
Literatur
1.
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–253.
2.
American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
3.
Burwell CS, Robin ED, Whaley RD, et al. Extreme obesity associated with alveolar hypoventilation—a Pickwickian syndrome. Am J Med. 1956;21:811–8.CrossRefPubMed
4.
Dickens C. The posthumous papers of the Pickwick Club. London: Chapman & Hall; 1837.
5.
Fothergill J. Case of an angina pectoris. In: Elliot J, editor. Complete collection of the medical and philosophical works. London: John Walker; 1781. p. 525.
6.
7.
Carroll D. Nosology of “Pickwickian syndrome”. Bull Physiopathol Respir. 1972;8:1241–7.
8.
Rapoport DM. Obesity hypoventilation syndrome: more than just severe sleep apnea. Sleep Med Rev. 2011;15:77–8.CrossRefPubMed
9.
Strumpf DA, Millman RP, Hill NS. The management of chronic hypoventilation. Chest. 1990;98:474–80.CrossRefPubMed
10.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311:806–14.CrossRefPubMed
11.
Hashimoto S, Tatsumi K, Osamu O, et al. Estimated numbers of patients with intractable respiratory diseases. Nihon Kokyuki Gakkai Zasshi. 1998;36:1006–10.PubMed
12.
Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care. 2010;55:1347–62.PubMed
13.
14.
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–14.PubMedCentralCrossRefPubMed
15.
Ganesh S, Alapat P. The prevalence of obesity hypoventilation syndrome in an inner city population. Chest. 2007;132:651S.CrossRef
16.
Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest. 2009;136:787–96.PubMed
17.
Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. 2004;116:1–7.CrossRefPubMed
18.
Crapo RO, Jensen RL, Hegewald M, Tashkin DP. Arterial blood gas reference values for sea level and at altitude of 1,400 meters. Am J Respir Crit Care Med. 1999;160:1525–31.CrossRefPubMed
19.
Bülbül Y, Ayik S, Ozlu T, Orem A. Frequency and predictors of obesity hypoventilation in hospitalized patients at a tertiary health care institution. Ann Thorac Med. 2014;9:87–91.PubMedCentralCrossRefPubMed
20.
Chau EHL, Lam D, Wong J, Mokhlesi B, Chung F. Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology. 2012;117:188–205.CrossRefPubMed
21.
Domínguez-Cherit G, Gonzalez R, Borunda D, Pedroza J, Gonzalez-Barranco J, Herrera MF. Anesthesia for morbidly obese patients. World J Surg. 1998;22:969–73.CrossRefPubMed
22.
Waltemath CL, Bergman NA. Respiratory compliance in obese patients. Anesthesiology. 1974;41:84–5.CrossRefPubMed
23.
Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis. 1982;126:640–5.PubMed
24.
Watson RA, Pride NB. Postural changes in lung volumes and respiratory resistance in subjects with obesity. J Appl Physiol (1985). 2005;98(2):512–7.CrossRef
25.
Yap JC, Watson RA, Gilbey S, Pride NB. Effects of posture on respiratory mechanics in obesity. J Appl Physiol (1985). 1995;79:1199–205.
26.
Sharp JT, Henry JP, Sweany SK, et al. Total respiratory system inertance and its gas and tissue components in normal and obese men. J Clin Invest. 1964;43:503–9.PubMedCentralCrossRefPubMed
27.
Brown LK, Schwartz J, Miller A, Pilipski M, Teirstein AS. Respiratory drive and pattern during inertially-loaded C02 rebreathing—implications for models of respiratory mechanics in obesity. Respir Physiol. 1990;80:231–44.CrossRefPubMed
28.
Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest. 1997;111:891–8.CrossRefPubMed
29.
Zerah F, Harf A, Perlemuter L, Lorino H, Lorino AM, Atlan G. Effects of obesity on respiratory resistance. Chest. 1993;103:1470–6.CrossRefPubMed
30.
Rubinstein I, Zamel N, DuBarry L, Hoffstein V. Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med. 1990;112:828–32.CrossRefPubMed
31.
32.
Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175:661–6.PubMedCentralCrossRefPubMed
33.
Al-Alwan A, Bates JH, Chapman DG, Kaminsky DA, DeSarno MJ, Irvin CG, et al. The nonallergic asthma of obesity. A matter of distal lung compliance. Am J Respir Crit Care Med. 2014;189:1494–502.PubMedCentralCrossRefPubMed
34.
Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med. 1999;160:883–6.CrossRefPubMed
35.
Naimark A, Cherniack RM. Compliance of the respiratory system and its components in health and obesity. J Appl Physiol. 1960;15:377–82.PubMed
36.
Pelosi P, Croci M, Ravagnan I, et al. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest. 1996;109:144–51.CrossRefPubMed
37.
Steier J, Jolley CJ, Seymour J, Roughton M, Polkey MI, Moxham J. Neural respiratory drive in obesity. Thorax. 2009;64(8):719–25.CrossRefPubMed
38.
Burki NK, Baker RW. Ventilatory regulation in eucapnic morbid obesity. Am Rev Respir Dis. 1984;129:538–43.PubMed
39.
Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med. 1983;75:81–90.CrossRefPubMed
40.
41.
Farkas GA, Gosselin LE, Zhan WZ, Schlenker EH, Sieck GC. Histochemical and mechanical properties of diaphragm muscle in morbidly obese Zucker rats. J Appl Physiol (1985). 1994;77:2250–9.
42.
Leech J, Onal E, Aronson R, Lopata M. Voluntary hyperventilation in obesity hypoventilation. Chest. 1991;100:1334–8.CrossRefPubMed
43.
De Vito EL, Montiel GC, Semeniuk GB. Diaphragmatic reserve strength in obese patients. Medicina (B Aires). 1991;51:524–8.
44.
Chlif M, Keochkerian D, Mourlhon C, Choquet D, Ahmaidi S. Noninvasive assessment of the tension-time index of inspiratory muscles at rest in obese male subjects. Int J Obes (Lond). 2005;29:1478–83.CrossRef
45.
Chlif M, Keochkerian D, Feki Y, Vaidie A, Choquet D, Ahmaidi S. Inspiratory muscle activity during incremental exercise in obese men. Int J Obes (Lond). 2007;31:1456–63.CrossRef
46.
Bellemare F, Grassino A. Evaluation of human diaphragm fatigue. J Appl Physiol Respir Environ Exerc Physiol. 1982;53:1196–206.PubMed
47.
Ramonatxo M, Boulard P, Préfaut C. Validation of a noninvasive tension-time index of inspiratory muscles. J Appl Physiol (1985). 1995;78:646–53.
48.
Sampson MG, Grassino AE. Load compensation in obese patients during quiet tidal breathing. J Appl Physiol. 1983;55:1269–76.PubMed
49.
Chlif M, Keochkerian D, Choquet D, Vaidie A, Ahmaidi S. Effects of obesity on breathing pattern, ventilatory neural drive and mechanics. Respir Physiol Neurobiol. 2009;168(3):198–202.CrossRefPubMed
50.••
Javaheri S, Simbarti LA. Respiratory determinants of diurnal hypercapnia in obesity hypoventilation syndrome. What does weight have to do with it? Ann Am Thorac Soc. 2014;11:945–50. In a study of 12 hypercapnic and 20 eucapnic obese patients with OSA, AHIs and awake alveolar and dead space ventilation did not differ significantly but hypercapnic subjects had higher CO 2 production.
51.
Hedenstierna G, Santesson J. Breathing mechanics, dead space and gas exchange in the extremely obese, breathing spontaneously and during anaesthesia with intermittent positive pressure ventilation. Acta Anaesthesiol Scand. 1976;20:248–54.CrossRefPubMed
52.•
Hollier CA, Harmer AR, Maxwell LJ, et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax. 2014;69:346. As the title states, this study provided additional evidence against the empiric use of supplemental oxygen in patient with OHS.CrossRefPubMed
53.
Wijesinghe M, Williams M, Perrin K, Weatherall M, Beasley R. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest. 2011;139:1018–24.CrossRefPubMed
54.
Holley HS, Milic-Emili J, Becklake MR, Bates DV. Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest. 1967;46:475–81.PubMedCentralCrossRefPubMed
55.
Barrera F, Reidenberg MM, Winters WL, Hungspreugs S. Ventilation-perfusion relationships in the obese patient. J Appl Physiol. 1969;26:420–6.PubMed
56.•
Rivas E, Arismendi E, Agustí A, et al. Ventilation/perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery. Chest. 2015;147:1127–34. Study in 19 morbidly obese women and 8 age-matched normal weight healthy female controls that used the multiple inert gas elimination technique to demonstrate ventilation/perfusion abnormality in the morbidly obese individuals that improved following weight loss due to bariatric surgery.CrossRefPubMed
57.
Farebrother MJ, McHardy GJ, Munro JF. Relation between pulmonary gas exchange and closing volume before and after substantial weight loss in obese subjects. Br Med J. 1974;3:391–3.PubMedCentralCrossRefPubMed
58.
Hedenstierna G, Santesson J, Norlander O. Airway closure and distribution of inspired gas in the extremely obese, breathing spontaneously and during anaesthesia with intermittent positive pressure ventilation. Acta Anaesthesiol Scand. 1976;20:334–42.CrossRefPubMed
59.
Jokic R, Zintel T, Sridhar G, Gallagher CG, Fitzpatrick MF. Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Thorax. 2000;55:940–5.PubMedCentralCrossRefPubMed
60.
Javaheri S, Colangelo G, Corser B, Zahedpour MR. Familial respiratory chemosensitivity does not predict hypercapnia of patients with sleep apnea-hypopnea syndrome. Am Rev Respir Dis. 1992;145:837–40.CrossRefPubMed
61.
Gastaut H, Tassinari CA, Duron B. Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome. Rev Neurol (Paris). 1965;112:568–79.
62.
Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the “Pickwickian syndrome”. Chest. 1986;89:627–35.CrossRefPubMed
63.
Rapoport DM, Norman RG, Goldring RM. CO2 homeostasis during periodic breathing: predictions from a computer model. J Appl Physiol. 1993;75:2302–9.PubMed
64.
Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. CO2 homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol. 2000;88:257–64.PubMed
65.
Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. Postevent ventilation as a function of CO(2) load during respiratory events in obstructive sleep apnea. J Appl Physiol. 2002;93:917–24.CrossRefPubMed
66.
Ayappa I, Berger KI, Norman RG, Oppenheimer BW, Rapoport DM, Goldring RM. Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2002;166:1112–5.CrossRefPubMed
67.
Berger KI, Ayappa I, Chatr-Amontri B, Marfatia A, Sorkin IB, Rapoport DM, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest. 2001;120:1231–8.CrossRefPubMed
68.
Norman RG, Goldring RM, Clain JM, Oppenheimer BW, Charney AN, Rapoport DM, et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol. 2006;100:1733–41.CrossRefPubMed
69.
Klein S, Coppack SW, Mohamed-Ali V, et al. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes. 1996;45:984–7.CrossRefPubMed
70.
Tankersley CG, O’Donnell C, Daood MJ. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol. 1998;85:2261–9.PubMed
71.
Ryan S, Crinion SJ, McNicholas WT. Obesity and sleep-disordered breathing-when two “bad guys” meet. Q J Med. 2014;107:949–54.CrossRef
72.
73.
Campo A, Frühbeck G, Zulueta JJ, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J. 2007;30:223–31.CrossRefPubMed
74.•
Bernhardt V, Lorenzo S, Babb TG, Zavorsky GS. Corrected end-tidal PCO2 accurately estimates PaCO2 at rest and during exercise in morbidly obese adults. Chest. 2013;143:471–7. Since most OHS patient are typically evaluated in outpatient sleep disorders centers without the ability to obtain arterial blood gas measurements, end-tidal pCO 2 may provide a viable screening tool to identify such individuals and guide appropriate testing and management.
75.
Liu SY, Lee TS, Bongard F. Accuracy of capnography in nonintubated surgical patients. Chest. 1992;102:1512–5.CrossRefPubMed
76.•
Mandal S, Suh ES, Boleat E, et al. A cohort study to identify simple clinical tests for chronic respiratory failure in obese patients with sleep-disordered breathing. BMJ Open Respir Res. 2014;1(1):e000022. doi:10.​1136/​bmjresp-2014-000022. Another study that identifies a means to screen morbidly obese patients for OHS in outpatient sleep disorders centers that typically lack the ability to obtain arterial blood gas measurements. In this analysis of 245 morbidly obese patients, awake pulse oximetry and FVC had moderate success in identifying individuals with OHS.PubMedCentralCrossRefPubMed
77.
Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007;11:117–24.CrossRefPubMed
78.
Trakada GP, Steiropoulos P, Nena E, Constandinidis TC, Bouros D. Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath. 2010;14:381–6.CrossRefPubMed
79.••
Manuel ARG, Hart N, Stradling JR. Is a raised bicarbonate, without hypercapnia, part of the physiologic spectrum of obesity-related hypoventilation? Chest. 2015;147:362–8. Elevated base excess may be helpful in identifying patients who are at risk of developing OHS and afford the opportunity to intervene earlier in the course of the disease.CrossRefPubMed
80.
Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am Rev Respir Dis. 1983;128:177–81.CrossRefPubMed
81.••
Ojeda Castillejo E, de Lucas RP, Martin SL. Noninvasive mechanical ventilation in patients with obesity hypoventilation syndrome. Long-term outcome and prognostic factors. Arch Bronconeumol. 2015;51(2):61–8. One of the few studies in the OHS literature that separately examined patients with and without OSA. Subjects without OSA had higher PaCO 2 and were more frequently hospitalized. The groups did not differ with respect to overall mortality, which was, as would be expected, high in view of the degree of obesity. At 8 years (the approximate length of the overall follow-up), survival was only 60%. Lower FVC predicted lower survival in both groups.
82.••
Piper A. Obesity hypoventilation syndrome: weighing in on therapy options. Chest. 2015. doi:10.​1378/​chest.​15-0681. Comprehensive, state-of-the-art review of current thinking on best-practice treatment of OHS.PubMed
83.••
Masa JF, Corral J, Alonso ML. Efficacy and different treatment alternatives for obesity hypoventilation syndrome: Pickwick study. Am J Respir Crit Care Med. 2015;192:86–95. An impressive multicenter RCT comparing AVAPS, CPAP, and lifestyle modification (control group) using daytime PaCO 2 as the primary outcome measure plus several important secondary outcome variables. Both AVAPS and CPAP were more effective in improving PaCO 2 in comparison to lifestyle modification, and there was no significant difference between the active treatments. Of the secondary outcome measures, 6-minute walk distance, health related quality of life, and spirometric variables were better with AVAPS treatment compared to CPAP.
84.•
Borel JC, Tamisier R, Gonzalez-Bermejo, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141:692–702. These investigators compared CPAP therapy to lifestyle modification (as the control treatment) in patients with milder degrees of OHS. They reported significant improvements in PaCO 2 in the CPAP group that were not attained in the lifestyle improvement cohort.
85.
Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63:395–401.CrossRefPubMed
86.
Howard M, Piper A, Stevens B, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Eur Respir J. 2014;44 Suppl 58:4868.
87.••
Murphy PB, Davidson C, Hind MD, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012;67:727–34. A two-center RCT in which treatment with bilevel PAP-S/T was compared to AVAP in patients with morbid obesity and OHS. No between-group differences were found for PaCO 2 improvement, daytime sleepiness, health related quality of life, or sleep quality assess by actigraphy.
88.
Janssens JP, Metzger M, Sforza E. Impact of volume targeting on efficacy of bi-level non-invasive ventilation and sleep in obesity-hypoventilation. Respir Med. 2009;103:165–72.CrossRefPubMed
89.
Storre JH, Seuthe B, Fiechter R, et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest. 2006;130:815–21.CrossRefPubMed
90.•
Contal O, Adler D, Borel JC, et al. Impact of different back-up respiratory rates on the efficacy of non-invasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest. 2013;143:37–46. This RCT pitted bilevel PAP-S against bilevel PAP-S/T employing either a low backup rate or a high backup rate in patients with OHS. Outcomes were assessed during single nights of polysomnography on each modality. Transcutaneous pCO 2 was similar for all 3 treatments. Bilevel PAP-S/T using either backup rate strategy was superior to spontaneous mode bilevel in terms of better resolution of respiratory events and fewer oxyhemoglobin desaturations. Bilevel PAP-S/T with the low backup rate was perceived by the patients as allowing better sleep quality and fewer arousals.
91.
Fletcher EC, Shah A, Qian W, Miller 3rd CC. “Near miss” death in obstructive sleep apnea: a critical care syndrome. Crit Care Med. 1991;19:1158–64.CrossRefPubMed
92.
Marik PE, Desai H. Characteristics of patients with the “malignant obesity hypoventilation syndrome” admitted to an ICU. J Intensive Care Med. 2013;28:124–30.CrossRefPubMed
93.
Sugerman HJ, Fairman RP, Lindeman AK, Mathers JA, Greenfield LJ. Gastroplasty for respiratory insufficiency of obesity. Ann Surg. 1981;193:677–85.PubMedCentralCrossRefPubMed
94.
De Cesare A, Cangemi B, Fiori E, Bononi M, Cangemi R, Basso L. Early and long-term clinical outcomes of bilio-intestinal diversion in morbidly obese patients. Surg Today. 2014;44:1424–33.CrossRefPubMed
95.
Lumachi F, Marzano B, Fanti G, Basso SM, Mazza F, Chiara GB. Hypoxemia and hypoventilation syndrome improvement after laparoscopic bariatric surgery in patients with morbid obesity. In Vivo. 2010;24:329–31.PubMed
96.
Martí-Valeri C, Sabaté A, Masdevall C, Dalmau A. Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass. Obes Surg. 2007;17:1102–10.CrossRefPubMed
97.
Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992;55(2 Suppl):597S–601.PubMed
98.
Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.CrossRefPubMed
99.
Carmody BJ, Sugerman HJ, Kellum JM, et al. Pulmonary embolism complicating bariatric surgery: detailed analysis of a single institution’s 24-year experience. J Am Coll Surg. 2006;203:831–7.CrossRefPubMed
100.
McKenzie R, Wadhwa RK. Progesterone for the Pickwickian syndrome: respiratory implications: a case report. Anesth Analg. 1977;56:133–5.CrossRefPubMed
101.
Sutton Jr FD, Zwillich CW, Creagh CE, Pierson DJ, Weil JV. Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med. 1975;83:476–9.CrossRefPubMed
102.
Raurich JM, Rialp G, Ibáñez J, Llompart-Pou JA, Ayestarán I. Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO2 response and acetazolamide treatment effects. Respir Care. 2010;55:1442–8.PubMed
103.••
Castro-Anon O, Perez de Llano LA, De la Fuente Sanchez S, et al. Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One. 2015;10(2):e0117808. doi:10.​1371/​journal.​pone.​0117808. Retrospective analysis of 330 patients with OHS (most also had OSA) or OSA alone demonstrating a two-fold increase in mortality for the patients with OHS.PubMedCentralCrossRefPubMed
104.•
Jennum P, Ibsen R, Kjellberg J. Morbidity prior to a diagnosis of sleep-disordered breathing: a controlled national study. J Clin Sleep Med. 2013;9:103–8. The authors analyzed data from the Danish National Patient Registry (1998–2006) to extract causes of morbidity in patients with OSA and OHS during the 3 years prior to their diagnosis. There were 755 OHS patients matched to 3020 controls. Of note, diabetes (and diabetic retinopathy), heart failure, hypertension, COPD, and asthma were more common in patients with OHS. The odds ratios for diabetes, hypertension, heart failure, COPD with acute exacerbation, and COPD were 4.16, 5.61, 5.02, 3.07, and 2.53, respectively.PubMedCentralPubMed
105.
Kauppert CA, Dvorak I, Kollert F, et al. Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med. 2013;107:2061–70.CrossRefPubMed
Metadaten
Titel
Obesity Hypoventilation Syndrome
verfasst von
Lee K. Brown
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
Current Sleep Medicine Reports / Ausgabe 4/2015
Elektronische ISSN: 2198-6401
DOI
https://doi.org/10.1007/s40675-015-0026-8

Weitere Artikel der Ausgabe 4/2015

Current Sleep Medicine Reports 4/2015 Zur Ausgabe

Sleep Epidemiology (J Nieto, Section Editor)

Exercise and Sleep in Community-Dwelling Older Adults

Sleep Epidemiology (J Nieto, Section Editor)

The Association Between Sleep Duration and Leptin, Ghrelin, and Adiponectin Among Children and Adolescents

Sleep Epidemiology (J Nieto, Section Editor)

The Relationships Among Sleep, Nutrition, and Obesity

Sleep Epidemiology (J Nieto, Section Editor)

Mobile Devices and Insomnia: Understanding Risks and Benefits

Sleep Epidemiology (J Nieto, Section Editor)

Chronotype and Health Outcomes

Sleep Epidemiology (J Nieto, Section Editor)

Recent Updates in the Social and Environmental Determinants of Sleep Health

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise